
Sign up to save your podcasts
Or


Alastair and Praveen are joined by Dr. Campbell Rogers, CMO and executive VP at HeartFlow, to discuss the recently-published FORECAST trial. What are the economic and clinical outcomes of selective FFRct use in stable chest pain? Tune in and enjoy!
By SCCT: Society of Cardiovascular Computed Tomography5
2222 ratings
Alastair and Praveen are joined by Dr. Campbell Rogers, CMO and executive VP at HeartFlow, to discuss the recently-published FORECAST trial. What are the economic and clinical outcomes of selective FFRct use in stable chest pain? Tune in and enjoy!

90,762 Listeners

168 Listeners

40 Listeners

886 Listeners

3,350 Listeners

112,482 Listeners

137 Listeners

39 Listeners

4 Listeners

425 Listeners

10,041 Listeners

36 Listeners

14 Listeners